Adrenal gland cancer, Secondary cancers
Open
Phase 2
This trial is looking at a new drug called CY-101 for adrenal cortical cancer.
It is for people:
whose cancer has spread into surrounding tissues or to another part of the body
who have no options available
This trial is supported by Cancer Research UK.
Recruitment start: 16 April 2026
Recruitment end: 30 September 2029
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Debashis Sarker
Cancer Research UK (Centre for Drug Development)
The Norwegian Cancer Society
CytovationASA
This is Cancer Research UK trial number CRUKD/25/001.
Last reviewed: 08 May 2026
CRUK internal database number: 20151
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
